LeMaitre Vascular, Inc.

LMAT ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Operating Activities
Net Income $17.2M $10.6M $7.8M $3.9M $3.2M $2.6M $2.1M $6.0M
Depreciation & Amortization $4.1M $3.6M $3.4M $3.3M $2.8M $2.2M $2.0M $1.4M
Depreciation $2.3M $2.0M $1.9M $1.8M $1.6M $1.3M $1.0M $693.0K
Amortization $1.8M $1.6M $1.5M $1.5M $1.2M $915.0K $990.0K $683.0K
Stock-Based Compensation $2.3M $1.7M $1.4M $1.3M $1.3M $1.2M $1.1M $967.0K
Net Cash from Operating Activities $22.9M $16.9M $11.4M $5.5M $5.4M $4.7M $3.2M $7.1M
Investing Activities
Capital Expenditures $6.4M $2.8M $2.3M $1.2M $2.7M $1.2M $2.0M $2.5M
Business Acquisitions — $14.4M $1.6M $6.6M $3.3M $4.4M $1.2M $3.5M
Net Cash from Investing Activities $-29.0M $-17.2M — — $-6.2M $-5.2M $-1.8M $-5.2M
Financing Activities
Dividends Paid $4.2M $3.3M $2.8M $2.3M $1.8M $1.5M $1.2M —
Stock Repurchases $778.0K $311.0K $266.0K $211.0K $373.0K $2.0M $2.2M $2.5M
Net Cash from Financing Activities $80.0K $-2.6M — — $-961.0K $-3.2M $-3.8M $-2.3M
Net Change in Cash $-5.2M $-3.2M $8.8M $4.0M $-1.7M $-3.7M $-2.5M $-578.0K
Free Cash Flow $16.5M $14.1M $9.2M $4.3M $2.7M $3.5M $1.1M $4.6M
← Newer Page 2 of 3 Older →